CCL2 and cancer: Collectively, these results provide evidence showing that imperatorin may inhibit TGFβ2 expression in cancer cells to suppress CAFs‐secreted CCL2 and the subsequent paracrine effect on endothelial cells and cancer cells, therefore, blocking tumor angiogenesis and invasion.